ATE365170T1 - Komplexverbindungen aus paramagnetischem metall und phthalocyanin und kontrastmittel, bei dem diese verbindungen verwendet werden - Google Patents

Komplexverbindungen aus paramagnetischem metall und phthalocyanin und kontrastmittel, bei dem diese verbindungen verwendet werden

Info

Publication number
ATE365170T1
ATE365170T1 AT02727019T AT02727019T ATE365170T1 AT E365170 T1 ATE365170 T1 AT E365170T1 AT 02727019 T AT02727019 T AT 02727019T AT 02727019 T AT02727019 T AT 02727019T AT E365170 T1 ATE365170 T1 AT E365170T1
Authority
AT
Austria
Prior art keywords
compounds
phthalocyanine
paramagnetic metal
contrast agent
complex
Prior art date
Application number
AT02727019T
Other languages
English (en)
Inventor
Seung-Yong Lee
Kyo-Yim Koo
Original Assignee
Seung-Yong Lee
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from KR10-2002-0000030A external-priority patent/KR100448100B1/ko
Application filed by Seung-Yong Lee filed Critical Seung-Yong Lee
Application granted granted Critical
Publication of ATE365170T1 publication Critical patent/ATE365170T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/22Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/04X-ray contrast preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/06Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/085Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier conjugated systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/06Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10Organic compounds
    • A61K49/101Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals
    • A61K49/106Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals the complex-forming compound being cyclic, e.g. DOTA
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F13/00Compounds containing elements of Groups 7 or 17 of the Periodic Table
    • C07F13/005Compounds without a metal-carbon linkage
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/003Compounds containing elements of Groups 3 or 13 of the Periodic Table without C-Metal linkages
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09BORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B47/00Porphines; Azaporphines
    • C09B47/04Phthalocyanines abbreviation: Pc
    • C09B47/06Preparation from carboxylic acids or derivatives thereof, e.g. anhydrides, amides, mononitriles, phthalimide, o-cyanobenzamide
    • C09B47/067Preparation from carboxylic acids or derivatives thereof, e.g. anhydrides, amides, mononitriles, phthalimide, o-cyanobenzamide from phthalodinitriles naphthalenedinitriles, aromatic dinitriles prepared in situ, hydrogenated phthalodinitrile
    • C09B47/0673Preparation from carboxylic acids or derivatives thereof, e.g. anhydrides, amides, mononitriles, phthalimide, o-cyanobenzamide from phthalodinitriles naphthalenedinitriles, aromatic dinitriles prepared in situ, hydrogenated phthalodinitrile having alkyl radicals linked directly to the Pc skeleton; having carbocyclic groups linked directly to the skeleton

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Radiology & Medical Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT02727019T 2001-01-05 2002-01-04 Komplexverbindungen aus paramagnetischem metall und phthalocyanin und kontrastmittel, bei dem diese verbindungen verwendet werden ATE365170T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20010000555 2001-01-05
KR10-2002-0000030A KR100448100B1 (ko) 2001-01-05 2002-01-02 상자성 금속-프탈로시아닌 착화합물 및 이를 이용한영상화용 조영제

Publications (1)

Publication Number Publication Date
ATE365170T1 true ATE365170T1 (de) 2007-07-15

Family

ID=26638699

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02727019T ATE365170T1 (de) 2001-01-05 2002-01-04 Komplexverbindungen aus paramagnetischem metall und phthalocyanin und kontrastmittel, bei dem diese verbindungen verwendet werden

Country Status (8)

Country Link
US (1) US7005517B2 (de)
EP (1) EP1355913B1 (de)
JP (1) JP4020784B2 (de)
CN (1) CN1249070C (de)
AT (1) ATE365170T1 (de)
DE (1) DE60220765T2 (de)
ES (1) ES2289099T3 (de)
WO (1) WO2002053570A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003096050A1 (en) * 2002-05-13 2003-11-20 Koninklijke Philips Electronics N.V. Magnetic resonance imaging method
BRPI0519754A2 (pt) 2005-01-13 2009-03-10 Cinv Ag materiais compàsitos contendo nanopartÍculas de carbono
BRPI0617450A2 (pt) * 2005-10-18 2011-07-26 Cinv Ag partÍculas de termocura e mÉtodos para produÇço das mesmas
US20090142273A1 (en) * 2006-06-08 2009-06-04 Case Western Reserve University Activatable cest MRI agent
WO2008087214A1 (en) * 2007-01-19 2008-07-24 Cinvention Ag Porous, non-degradable implant made by powder molding
WO2008104599A1 (en) * 2007-02-28 2008-09-04 Cinvention Ag High surface cultivation system bag
CN101646764A (zh) * 2007-02-28 2010-02-10 金文申有限公司 高表面积培养系统
CA2677722A1 (en) * 2007-02-28 2008-09-04 Cinvention Ag High surface cultivation system with filler
KR100773089B1 (ko) 2007-04-30 2007-11-05 씨엠에스테크놀로지(주) 감마선에 감응하는 폴리 가교형 프탈로시아닌 화합물 및 그를 포함하는 잉크 조성물
DE102009034189A1 (de) * 2009-07-17 2011-01-20 Berthold, Herwig, Dr. Neuartige, substituierte Phtalocyanin- und Azaphthalocyaninderivate, ihr Gebrauch und Verfahren zur Herstellung
WO2011034183A1 (ja) * 2009-09-17 2011-03-24 国立大学法人九州大学 ポルフィリン化合物
CN101812092B (zh) * 2010-04-27 2012-05-23 江苏大学 一种锰配合物及其制备方法和用途
KR20130056095A (ko) * 2011-11-21 2013-05-29 경희대학교 산학협력단 임상의사결정지원장치를 위한 데이터 처리 방법과 장치
JP5277469B1 (ja) * 2012-07-25 2013-08-28 東洋インキScホールディングス株式会社 π型フタロシアニン顔料、該π型フタロシアニン顔料の製造方法および該π型フタロシアニン顔料を用いた着色組成物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5622685A (en) * 1990-05-30 1997-04-22 Deutches Krebsforchunszentrum Stiftung Des Offentlichen Rechts Polyether-substituted porphyrin anti-tumor agents
CA2071474A1 (en) * 1991-06-19 1992-12-20 Hisato Itoh Phthalocyanine compounds and usage thereof
US5817292A (en) * 1992-10-14 1998-10-06 Nycomed Imaging As MR imaging compositions and methods
GB9405970D0 (en) * 1994-03-25 1994-05-11 Secr Defence Substituted phthalocyanines
IT1294325B1 (it) * 1997-08-14 1999-03-24 Molteni L E C Dei Fratelli Ali Zinco-ftalocianine e relativi coniugati, preparazione e uso nella terapia fotodinamica e come diagnostici
JP2001108831A (ja) * 1999-10-08 2001-04-20 Fuji Photo Film Co Ltd ランタニド錯体色素を含むディスコティック液晶膜からなる偏光シート

Also Published As

Publication number Publication date
DE60220765T2 (de) 2008-03-06
US7005517B2 (en) 2006-02-28
JP2004528280A (ja) 2004-09-16
CN1487947A (zh) 2004-04-07
ES2289099T3 (es) 2008-02-01
WO2002053570A1 (en) 2002-07-11
EP1355913A4 (de) 2006-04-26
EP1355913A1 (de) 2003-10-29
EP1355913B1 (de) 2007-06-20
CN1249070C (zh) 2006-04-05
JP4020784B2 (ja) 2007-12-12
US20040214810A1 (en) 2004-10-28
DE60220765D1 (de) 2007-08-02

Similar Documents

Publication Publication Date Title
ATE365170T1 (de) Komplexverbindungen aus paramagnetischem metall und phthalocyanin und kontrastmittel, bei dem diese verbindungen verwendet werden
MX2023010737A (es) Nuevo agente de contraste para utilizar en imagenes por resonancia magnetica.
Bendszus et al. MRI gadolinium‐based contrast media: meeting radiological, clinical, and environmental needs
ATE195432T1 (de) Iodierte paramagnetische chelaten, und deren verwendung als kontrastmittel
Veit-Haibach et al. TNM staging with FDG-PET/CT in patients with primary head and neck cancer
DK0907379T3 (da) Bioaktiveret diagnostisk billeddannelseskontrastmiddel
Ladefoged et al. PET/MR imaging of the pelvis in the presence of endoprostheses: reducing image artifacts and increasing accuracy through inpainting
IL198995A0 (en) Novel compound having affinity for amyloid
Kabalka et al. The use of positron emission tomography to develop boron neutron capture therapy treatment plans for metastatic malignant melanoma
DE69226669D1 (de) Neue makrocyclische Stickstoff-Liganden, Verfahren zu ihrer Herstellung, Metallkomplexe, diagnostische und therapeutische Zusammensetzungen
Catalano et al. An overview of PET/MR, focused on clinical applications
Fatouros et al. Metallofullerenes: a new class of MRI agents and more?
RU2008147002A (ru) Новые соединения, обладающие сродством к амилоиду
Bonlawar et al. Targeted nanotheranostics: integration of preclinical MRI and CT in the molecular imaging and therapy of advanced diseases
SG151073A1 (en) Contrast agent for use in imaging methods
Benz-Bohm et al. Focal nodular hyperplasia of the liver in longterm survivors of neuroblastoma: how much diagnostic imaging is necessary?
WO2001051095A3 (de) Paramagnetische dota-derivate, diese enthaltende pharmazeutische mittel, verfahren zu ihrer herstellung und ihre verwendung für das nekrose- und infarkt-mr-imaging
JP7692839B2 (ja) コンジュゲート及びそのイメージング剤としての使用
NO20080813L (no) Komplekser inneholdende perfluoralkyl, fremgangsmate for fremstilling og anvendelse derav
JP2005505527A5 (de)
Sun et al. In vivo evaluation of copper-64-labeled monooxo-tetraazamacrocyclic ligands
JP2006505616A5 (de)
Tateishi et al. Extraskeletal osteosarcoma: extensive tumor thrombus on fused PET-CT images
ATE347912T1 (de) Ionisches und nicht-ionisches radiographisches kontrastmittel zur verwendung in der kombinierten roentgen- und kernspintomographiediagnostik
DK0680464T3 (da) Derivatiserede DTPA-komplekser, farmaceutiske midler indeholdende disse forbindelser, deres anvendelse som NMR- og røntgenkontrastmidler og fremgangsmåde til fremstilling af forbindelserne

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties